Should β blockers be used in the treatment of hypertension in the elderly?

Journal of Clinical Hypertension

Volumn 4, Issue 4, 2002, Pages 286-294

  Prisant, L Michael ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; AMILORIDE; AMLODIPINE; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CHLORTALIDONE; DILEVALOL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; FELODIPINE; HYDROCHLOROTHIAZIDE; ISRADIPINE; LABETALOL; LISINOPRIL; LOSARTAN; METOPROLOL; NEBIVOLOL; NIFEDIPINE; PINDOLOL; PROPRANOLOL; RESERPINE;

AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; DRUG EFFICACY; FEMALE; HEART ARRHYTHMIA; HEART DEATH; HEART INFARCTION; HUMAN; HYPERTENSION; IMPOTENCE; ISCHEMIC HEART DISEASE; MALE; MORTALITY; RISK BENEFIT ANALYSIS; STATISTICAL ANALYSIS; STROKE;

EID: 0036342033     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2002.01250.x     Document Type: Article

References (82)

1. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991
2. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991
3. Management of drug therapy in the elderly
4. Hypertension in the elderly: Can we improve results of therapy?
5. Management of elderly patients with sustained hypertension
6. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review
7. The age factor in hypertension
8. Essential hypertension in the elderly: Haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels
9. Medical Research Council trial of treatment of hypertension in older adults: Principal results. MRC Working Party
10. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
11. Current hypertension management: Separating fact from fiction
12. MRC trial of treatment of mild hypertension: Principal results. Medical Research Council Working Party
13. Selective induction of propranolol metabolism by smoking: Additional effects on renal clearance of metabolites
14. Enalapril versus atenolol in the treatment of hypertensive smokers
15. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
16. Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: A report from the STOP-Hypertension study
17. Renin dependency of blood pressure in isolated systolic hypertension
18. Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years. Report from a double-blind international multicenter study
19. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo
20. Correction: Single-drug therapy for hypertension in men
21. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women
22. Use of beta-adrenergic receptor blockers in blacks
23. Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks
24. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
25. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators
26. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP)
27. Treatment of isolated systolic hypertension with labetalol in the elderly
28. A comparison of dilevalol and placebo in the management of isolated systolic hypertension using ambulatory monitoring
29. Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension
30. Antihypertensive efficacy and tolerability of different drug regimens in isolated systolic hypertension in the elderly
31. Felodipine, metoprolol and their combination compared with placebo in isolated systolic hypertension in the elderly
32. The efficacy and tolerability of losartan versus atenolol in patients with isolated systolic hypertension. Losartan ISH Investigators Group
33. Low-dose combination therapy in hypertension
34. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide
35. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension
36. Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment
37. Low-dose combination therapy as first line treatment of mild-to-moderate hypertension: The efficacy and safety of bisoprolol/HCTZ versus amlodipine, enalapril, and placebo
38. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension
39. Clinical Advisory Statement. Importance of systolic blood pressure in older Americans
40. Hypertension: The rediscovery of combination therapy
41. The importance of arterial compliance in cardiovascular drug therapy
42. Effect of lisinopril and metoprolol on arterial distensibility
43. Effects of beta-adrenergic blockade on the arterial vasculature in essential hypertension
44. Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension
45. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
46. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial
47. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results
48. Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol
49. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial
50. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: Comparison of six antihypertensive agents
51. Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol
52. The effects of antihypertensive therapy on left ventricular mass in elderly patients
53. Reversal of left ventricular hypertrophy in hypertensive patients. A meta-analysis of 109 treatment studies
54. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies
55. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: Rationale, design, and methods
56. Sexual dysfunction with antihypertensive drugs
57. Self reported sexual dysfunction in men and women treated with bisoprolol/hydrochlorothiazide, bisoprolol, hydrochlorothiazide, enalapril, amlodipine or placebo
58. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension
59. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)
60. Effect of antihypertensives on sexual function and quality of life: The TAIM Study
61. The effects of propranolol on cognitive function and quality of life: A randomized trial among patients with diastolic hypertension
62. Effects of antihypertensive drugs atenolol and nifedipine on sexual function in older men: A placebo-controlled, crossover study
63. Sexual function in hypertensive males treated with lisinopril or atenolol: A cross-over study
64. Sexual activity in hypertensive men treated with valsartan or carvedilol: A crossover study
65. Depression associated with antihypertensive drugs
66. Reflections on the impact of antihypertensive medication on mood, sedation, and neuropsychologic functioning
67. The effect of β blockers on mental performance on older hypertensive patients
68. Antihypertensive drug therapy and insulin resistance
69. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
70. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS
71. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension
72. Suppositions and speculations-their possible effects on treatment decisions in the management of hypertension
73. The treatment of hypertension in diabetic patients
74. The beta blockers: Are they as protective in hypertension as in other cardiovascular conditions?
75. Heart and Stroke Statistical Update
76. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
77. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
78. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
79. Effect of carvedilol on survival in severe chronic heart failure
80. Beta-blocker use in systolic heart failure and dilated cardiomyopathy
81. Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction